Picture of Santhera Pharmaceuticals Holding AG logo

SANN — Santhera Pharmaceuticals Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Santhera Partners Up With Ikris Pharma Network For Distribution Of Agamree In India

Aug 29 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG SANN.S:

ENTERS INTO AGREEMENT WITH IKRIS PHARMA NETWORK FOR THE DISTRIBUTION OF AGAMREE® (VAMOROLONE) IN INDIA

AGREEMENT BETWEEN SANTHERA AND IKRIS HAS A 5-YEAR TERM AND SANTHERA WILL RECEIVE A PERCENTAGE OF NET SALES

SALES ARE EXPECTED TO BEGIN IN Q4 2025 ON A NAMED PATIENT BASIS

Source text: ID:nGNX1jLQgl

Further company coverage: SANN.S

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Santhera Pharmaceuticals Holding AG

See all news